ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,651 | -12,016 | -5,959 | -3,811 | -2,611 |
| Depreciation Amortization | 101 | 102 | 93 | 92 | 93 |
| Other Working Capital | 901 | 899 | 151 | -244 | 677 |
| Other Operating Activity | 352 | 573 | 193 | 0 | 18 |
| Operating Cash Flow | $-8,298 | $-10,442 | $-5,522 | $-3,963 | $-1,824 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,308 | -16,099 | N/A | N/A | N/A |
| PPE Investments | -67 | -103 | -9 | -39 | -87 |
| Investing Cash Flow | $7,240 | $-16,202 | $-9 | $-39 | $-87 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 198 | 18,680 | 9,782 | 4,386 | 3,801 |
| Common Stock Repurchased | N/A | N/A | N/A | -3 | N/A |
| Financing Cash Flow | $198 | $18,680 | $9,782 | $4,383 | $3,801 |
| Beginning Cash Position | 1,170 | 9,134 | 4,884 | 4,502 | 2,612 |
| End Cash Position | 311 | 1,170 | 9,134 | 4,884 | 4,502 |
| Net Cash Flow | $-859 | $-7,964 | $4,251 | $381 | $1,891 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,298 | -10,442 | -5,522 | -3,963 | -1,824 |
| Capital Expenditure | -67 | -103 | -9 | -39 | -87 |
| Free Cash Flow | -8,365 | -10,546 | -5,531 | -4,002 | -1,911 |